Codexis Announces the Election of New Directors at its Annual Meeting of Stockholders REDWOOD CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, announces the election of new...

Vasomune Therapeutics and AnGes, Inc. enter into a Multi-Million Dollar Global Co-Development Agreement to Advance an Innovative Platform Targeting Vascular Leakage Tokyo, Japan and Toronto, Ontario, July 31, 2018 (GLOBE NEWSWIRE) -- Vasomune Therapeutics (“Vasomune”), a Toronto-based spin-out from Sunnybrook Research Institute and MaRS Innovation, and AnGes,...

John Poss, Chief Executive Officer of GB Sciences, Inc., Returns to Uptick Newswire’s “Stock Day” Podcast with Everett Jolly for Operational Update PHOENIX, Feb. 06, 2018 (GLOBE NEWSWIRE) -- GB Sciences, Inc. (OTCQB:GBLX) (the “company”), discusses 2017 achievements and 2018 operations expectations, on Stock Day Podcast with Everett Jolly. “It...

Cell Design Labs Appoints Roger Sidhu, M.D. as Chief Medical Officer EMERYVILLE, Calif., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Cell Design Labs, Inc. today announced the appointment of Roger Sidhu, M.D., to the newly created position of Chief Medical Officer. Dr. Sidhu...

Qu Biologics invited to present Research Data at International Scientific Meetings VANCOUVER, British Columbia, May 03, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...